Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9297 USD | -2.14% | +36.10% | -34.06% |
27/03 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
26/03 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Evolution of the average Target Price on Lucid Diagnostics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Lucid Diagnostics Inc.
Cantor Fitzgerald | |
Needham & Co. | |
BTIG | |
Canaccord Genuity | |
Ascendiant Capital |
EPS Revisions
- Stock Market
- Equities
- LUCD Stock
- Consensus Lucid Diagnostics Inc.